Search For
/
Stocks
Intraday Booster
Sector Booster
Stock Screener
Market Pulse
Screeners
More
Go Prime
My Plans
Privacy Policy
Contact
Refer & EarnScreenersMain
Stock Screener
Create Screener
Explore Screeners
Community ScreenersTrading Screeners
CandleSticks Screener
Top Gainers & Losers
Opening Range Breakout
Stock Screener AI
Stock Quality Scorecard
Overvalued StocksNewUndervalued StocksNewTechnical Screeners
NR4 Stocks
NR7 Stocks
Previous Day High Breakout
Previous Day Low Breakout
Previous Day Open Breakout
Bullish Crossover Stocks
Bearish Crossover Stocks
High Volume Shocker
VWAP Breakout Stocks
Range High Breakout
Range Low BreakoutMoreMarkets
Global Market Today
Global Indices
Indian Indices
NIfty TodaySmart Money
FII DII DataNew
FII Buying
NSE Insider Trading
SLB Stocks DataDerivatives
FnO Movements
NSE F&O Lot Size
Ban ListAnalysis & Calendars
Technical DashboardSector Booster
Sector AnalysisNew
Result Calendar
Economic Calendar
Indraprastha Medical Corporation
Small Cap•2,977 Employees•IPO 1997
Current Price
₹382.90
-15.75 (-3.95%)Updated
Today's Range
380
₹382.90
398.65
52 Week Range
52W Low₹307.25
52W High₹640.85
₹382.90
Downside24.62%
Upside67.37%
Price Chart
Compare with Peers
Historical Ratios
Track top 12 most important financial ratios
P/E Ratio: Price to Earnings - Most used valuation metric
Loading chart...
Analyzing Investment Quality
Processing 9 key metrics...
Key Metrics
Hover for details
Valuation
Market Cap
₹3,857.6 Cr
Market Cap
Total market value of companyP/E Ratio
22.08
P/E Ratio
Price to Earnings. Lower is generally better (<25 is good)P/B Ratio
6.19
P/B Ratio
Price to Book Value. <3 may indicate undervaluationEPS
₹19.06
EPS
Earnings Per Share. Higher and growing is positiveProfitability
ROE
14.42%
ROE
Return on Equity. >15% is good, >20% is excellentROCE
39.10%
ROCE
Return on Capital Employed. >15% is goodNet Margin
12.44%
Net Margin
Net profit as % of revenue. >10% is goodOperating Margin
-%
Operating Margin
Operating profit margin. >15% is goodGrowth
EPS Growth (5Y)
29.85%
EPS Growth (5Y)
5-year EPS growth. >15% is strongRevenue Growth (5Y)
10.30%
Revenue Growth (5Y)
5-year revenue growth. >10% is goodQtr Sales Growth
4.94%
Qtr Sales Growth
Quarter-over-quarter sales growthQtr Profit Growth
14.90%
Qtr Profit Growth
Quarter-over-quarter profit growthFinancial Health
Debt/Equity
0.05
Debt/Equity
Financial leverage. <1 is good, <0.5 is excellentBook Value
₹65.09
Book Value
Net asset value per shareDividend Yield
1.13%
Dividend Yield
Annual dividend as % of price. >2% is goodPromoter Holding
51.00%
Promoter Holding
Promoter stake. >50% shows confidenceGood
Average
Needs Attention
SWOT Analysis
Strengths
5 points- •Indraprastha Medical Corporation boasts a strong Return on Equity (ROE) of 30% and Return on Capital Employed (ROCE) of 39.10%, indicating highly efficient use of capital and robust profitability for shareholders.
- •The company demonstrates consistent growth with a 14.90% increase in quarterly profits and a 4.94% rise in quarterly sales, reflecting strong operational performance and market demand.
Weaknesses
4 points- •The current Price-to-Earnings (P/E) ratio of 31.20 is higher than the sector P/E of 26.13, suggesting the stock might be relatively overvalued compared to its industry peers.
- •The stock has shown some recent volatility, with a 5-day range from 536.75 to 603.00, indicating potential market uncertainty and short-term price fluctuations for investors.
Opportunities
3 points- •Operating in the robust 'Healthcare' sector, the company can capitalize on increasing demand for quality medical services driven by population growth and rising health awareness.
- •The company's strong financial position, marked by low debt and high profitability, provides a solid foundation for potential expansion or strategic acquisitions in the growing hospital industry.
Threats
3 points- •The company faces intense competition from larger, well-established players like Apollo Hospitals and Max Healthcare, which could impact market share and pricing power in the competitive healthcare sector.
- •The healthcare industry is subject to evolving regulatory changes and government policies, which could introduce compliance costs or impact operational flexibility and profitability.
Segment-wise Financial Analysis
Fetching Financials...
Fetching Balance Sheet...
Fetching Cash Flow...
Shareholding Pattern
Loading shareholding data...
Company Insider Trading Activity
No insider trading data available
Corporate Action
Company Announcements
Technical Analysis & Indicators
Standard pivot points - most widely used
Pivot Points (CLASSIC)
| Level | Price | Distance | % Change |
|---|---|---|---|
| R4 | ₹431.67 | +₹48.77 | +12.74% |
| R3 | ₹413.02 | +₹30.12 | +7.87% |
| R2 | ₹405.83 | +₹22.93 | +5.99% |
| R1 | ₹394.37 | +₹11.47 | +2.99% |
| PIVOT | ₹387.18 | 4.28 | 1.12% |
| CURRENT | ₹382.90 | - | - |
| S1 | ₹338.42 | -₹44.48 | -11.62% |
| S2 | ₹357.07 | -₹25.83 | -6.75% |
| S3 | ₹368.53 | -₹14.37 | -3.75% |
| S4 | ₹375.72 | -₹7.18 | -1.88% |
CPR Levels
Support
Resistance
S4
N/A
S3
N/A
S2
N/A
S1
N/A
| CPR |
BC: N/AP: N/ATC: N/A
R1
N/A
R2
N/A
R3
N/A
R4
N/A
LTP: N/A
PDH: N/A
PDL: N/A
● Market Sentiment
is trading CPR, indicating
● CPR Width
CPR is
● Opening Range
Day's range: ~
● Price Position
Trading Inside opening range
Delivery Volume Analysis & Trading Activity
Latest Volume+34.4% vs avg
2.18L
(13 Mar 2026)Delivery %+19.4% vs avg
74.5%
(13 Mar 2026)Avg Volume (20D)20-day average
1.62L
(13 Feb - 13 Mar)Avg Delivery %Trend ↑
55.1%
(13 Feb - 13 Mar)Delivery % indicates the percentage of traded volume that resulted in actual delivery. Higher delivery % (>50%) suggests genuine buying interest and stronger hands.
Peer Comparison & Industry Benchmarking
Quick Compare
Largest by Market Cap
Apollo Hospitals Enterprise Ltd
1.09L ₹ Cr
Best Profit Growth
Apollo Hospitals Enterprise Ltd
41.80 %
Highest Dividend Yield
Apollo Hospitals Enterprise Ltd
0.38 %
Peer Comparison
| Company Name |
|---|
 Apollo Hospitals Enterprise Ltd |
 Artemis Medicare Services Ltd |
 GPT Healthcare Ltd |
 Healthcare Global Enterprises Ltd |
 Jupiter Life Line Hospitals Ltd |
 |
 Max India Ltd |
 Shalby Ltd |
 Yatharth Hospital & Trauma Care Services Ltd |
About
Indraprastha Medical Corporation Ltd
Indraprastha Medical Corporation Limited (INDRAMEDCO) is a prominent healthcare provider in India, operating a multi-specialty hospital in New Delhi. Their business model centers around delivering a wide range of medical services under one roof, catering to diverse patient needs and offering comprehensive care.
The hospital's services span numerous medical specialties, reflecting a commitment to holistic patient care. These include core areas like general surgery (including laparoscopic and robotic procedures), cardiology, oncology, and orthopedics. They also offer specialized services in high-demand areas such as bariatric and metabolic surgery, bone marrow transplant, IVF (in-vitro fertilization), and transplant services in general. Further strengthening their comprehensive approach are offerings in areas like endocrinology, gastroenterology, neurology, and psychiatry.
Beyond surgical and specialist care, INDRAMEDCO provides extensive diagnostic and support services. These encompass laboratory services, radiology and radio diagnosis, and advanced imaging techniques like nuclear medicine. The hospital also has dedicated departments for anesthesiology, critical care, emergency medicine, and rehabilitation, ensuring complete patient management from diagnosis to recovery. Preventive health services and specialized care for geriatric patients (elder care) further enhance their service portfolio.
The breadth of services offered demonstrates INDRAMEDCO's strategy to be a one-stop healthcare destination. This minimizes the need for patients to seek care from multiple providers, improving efficiency and convenience. The incorporation of advanced technologies, such as robotic surgery and hyperbaric oxygen therapy, showcases a commitment to adopting modern medical practices and providing high-quality treatment.
Established in 1983, INDRAMEDCO has a long history of serving the healthcare needs of the New Delhi region. Their extensive service offering and commitment to various medical specialties position them as a significant player in the Indian healthcare landscape, focusing on providing comprehensive and advanced medical care.
COMPANY FACTS - INDRAMEDCO
Registered Address
Sarita Vihar,, Delhi-Mathura Road
New Delhi
DELHI
IN
Tel: 911129872126
Website:https://delhi.apollohospitals.com/
Investor Relations:http://www.apollohospitals.com/delhi/investor-relations/
Company Details
Group: Health Care Equipment & Services
Sector: Health Care
Industry: Health Care Providers & Services
Exchange: NATIONAL STOCK EXCHANGE OF INDIA
Employees: 2,977
IPO Date: 24/02/1997
MANAGEMENT - INDRAMEDCO
Mr. Jasmine Shah
Non-Executive Chairman of the Board
Dr. Prathap Reddy
Non-Executive Vice Chairman of the Board
Mr. C. Tyagi
Chief Financial Officer
Mr. Priya Ranjan
Compliance Officer, Company Secretary
Mr. P. Shivakumar
Managing Director, Executive Director
Mr. Vikram Bhat
Non-Executive Director
Mr. Udit Rai
Non-Executive Director
Ms. Sangita Reddy
Non-Executive Director
Ms. Suneeta Reddy
Non-Executive Director
Prof. Dr. Mahesh Verma
Non-Executive Director
Mr. Vinayak Chatterjee
Non-Executive Independent Director
Mr. Tejpreet Chopra
Non-Executive Independent Director
Investor Questions Answered
Indraprastha Medical Corporation Ltd (INDRAMEDCO) Stock FAQs
Get answers to the most common questions about Indraprastha Medical Corporation Ltd stock price, fundamentals, financial metrics, and investment analysis
The current share price of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹382.9. Today, the stock has declined by ₹15.75 (3.95%), trading in a range of ₹380 to ₹398.65. The stock opened at ₹398.65 with a trading volume of 2,17,703 shares.
Indraprastha Medical Corporation Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹3,857.6 crores, P/E ratio of 22.08, ROE of 14.42%, and ROCE of 39.10%. The dividend yield stands at 1.13%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
The 52-week high price of Indraprastha Medical Corporation Ltd (INDRAMEDCO) is ₹640.85, while the 52-week low is ₹307.25. Currently trading at ₹382.9, the stock is 22.7% away from its 52-week low and 40.3% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
Whether to buy Indraprastha Medical Corporation Ltd stock at ₹382.9 depends on multiple factors. The stock is currently trading with a P/E ratio of 22.08 and P/B ratio of N/A. Today's performance shows a loss of 3.95%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
Indraprastha Medical Corporation Ltd offers a dividend yield of 1.13%, which means for every ₹100 invested at the current price of ₹382.9, you can expect to receive approximately ₹1.13 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
Indraprastha Medical Corporation Ltd's key financial metrics include: P/E Ratio: 22.08, P/B Ratio: N/A, ROE: 14.42%, ROCE: 39.10%, Dividend Yield: 1.13%, EPS: ₹19.06, Book Value: ₹65.09, Debt-to-Equity: 0.05, and Current Ratio: N/A. The company's market cap stands at ₹3,857.6 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
Indraprastha Medical Corporation Ltd stock opened at ₹398.65 and is currently trading at ₹382.9, showing a decline of ₹15.75 (3.95%). The intraday high is ₹398.65 and low is ₹380. The trading volume stands at 2,17,703 shares, indicating moderate market participation today.
Indraprastha Medical Corporation Ltd has a Price-to-Earnings (P/E) ratio of 22.08, which means investors are willing to pay ₹22.08 for every ₹1 of earnings. With an EPS of ₹19.06, this P/E ratio indicates moderate valuation in line with market standards. Compare this with industry peers and historical P/E ratios for better context.
Indraprastha Medical Corporation Ltd has a market capitalization of ₹3,857.6 crores, making it a small-cap company. Market cap is calculated by multiplying the current stock price (₹382.9) by the total number of outstanding shares. This metric helps investors understand the company's size, stability, and investment risk profile.
Indraprastha Medical Corporation Ltd has a book value of ₹65.09 per share and a Price-to-Book (P/B) ratio of N/A. The current market price is ₹382.9, which is 488.3% above the book value. A P/B ratio below 1 may indicate undervaluation or asset quality concerns.
Indraprastha Medical Corporation Ltd has a Return on Equity (ROE) of 14.42% and Return on Capital Employed (ROCE) of 39.10%. ROE measures how efficiently the company generates profits from shareholders' equity, while ROCE indicates how well the company uses its capital to generate profits. These are moderate returns, suggesting decent operational efficiency. Higher percentages generally indicate better financial performance.
Indraprastha Medical Corporation Ltd operates in the diversified sector and belongs to the general industry. The company competes with other players in this space and its performance is influenced by sector-specific trends, regulatory changes, and market dynamics. Understanding the sector helps investors assess growth potential, cyclical patterns, and industry-specific risks that may impact the stock's performance.
Indraprastha Medical Corporation Ltd has a debt-to-equity ratio of 0.05, which measures the company's financial leverage by comparing total debt to shareholders' equity. A low ratio suggests conservative financing with minimal debt. Lower ratios generally indicate lower financial risk, but optimal levels vary by industry.
Indraprastha Medical Corporation Ltd has an Earnings Per Share (EPS) of ₹19.06, which represents the company's profit allocated to each outstanding share. With a current stock price of ₹382.9 and P/E ratio of 22.08, investors are paying 22.08 times the annual earnings per share. The company may need to improve its earnings performance. Track EPS growth over quarters to assess earnings momentum.
Indraprastha Medical Corporation Ltd has reported a sales growth of N/A% and profit growth of N/A%. The company may be facing growth challenges or operating in a mature market. Consistent growth over multiple quarters is a positive indicator for long-term investors. Compare these growth rates with industry peers for better perspective.
Indraprastha Medical Corporation Ltd has a current ratio of N/A, which measures the company's ability to pay short-term obligations with current assets. A ratio below 1 may indicate potential liquidity concerns. This metric is crucial for assessing the company's working capital management and financial safety.
To analyze Indraprastha Medical Corporation Ltd stock, consider: 1) Fundamental Analysis - Review P/E (22.08), ROE (14.42%), debt-to-equity (0.05), and growth rates. 2) Technical Analysis - Check 52-week range (₹307.25 - ₹640.85), moving averages, and chart patterns. 3) Valuation - Compare current price (₹382.90) with book value (₹65.09) and industry peers. 4) Financial Health - Assess current ratio (N/A) and cash flows. 5) Growth Prospects - Evaluate sales growth (N/A%) and profit growth (N/A%). Always diversify and consult a financial advisor.
The face value (or par value) of Indraprastha Medical Corporation Ltd share is ₹10.00. Face value is the nominal value of a share as stated in the company's charter and is used for accounting purposes and calculating dividends. The current market price of ₹382.9 is 3729x the face value. Face value remains constant unless the company undergoes a stock split or bonus issue, while market price fluctuates based on demand and supply.
Investing in Indraprastha Medical Corporation Ltd carries several risks: 1) Market Risk - Stock price volatility (52-week range: ₹307.25 - ₹640.85). 2) Business Risk - Industry-specific challenges in the sector. 3) Financial Risk - Debt-to-equity ratio of 0.05 indicates leverage. 4) Liquidity Risk - Based on trading volume of 2,17,703 shares. 5) Valuation Risk - P/E of 22.08 may indicate over/undervaluation. 6) Economic Risk - Macroeconomic factors affecting the industry. Diversify your portfolio and invest only what you can afford to lose.
Indraprastha Medical Corporation Ltd operates in the industry with key metrics: P/E ratio of 22.08, ROE of 14.42%, market cap of ₹3,857.6 crores, and dividend yield of 1.13%. To make an informed comparison, analyze these metrics against industry peers considering factors like revenue growth (N/A%), profit margins, debt levels (D/E: 0.05), and market position. Use our peer comparison tool on this page to see detailed side-by-side analysis with competitors.
Target prices for Indraprastha Medical Corporation Ltd vary among analysts and depend on multiple factors including earnings projections, industry trends, and market conditions. The stock is currently trading at ₹382.9, with a 52-week range of ₹307.25 to ₹640.85. Based on fundamentals like P/E (22.08), ROE (14.42%), and growth rates, analysts may have different target prices. Always refer to recent research reports from reputed brokerages and make decisions based on your own analysis and risk appetite.
Consider selling Indraprastha Medical Corporation Ltd stock when: 1) Target Price Achieved - If the stock reaches your predetermined target from current ₹382.90. 2) Fundamental Deterioration - Declining ROE (currently 14.42%), increasing debt (D/E: 0.05), or falling growth rates. 3) Better Opportunities - Finding stocks with superior risk-reward ratios. 4) Portfolio Rebalancing - When the stock becomes overweight in your portfolio. 5) Changed Investment Thesis - If reasons for buying no longer hold. 6) Stop Loss - If price falls below your risk threshold. Always base decisions on thorough analysis rather than emotions.
Tax implications for Indraprastha Medical Corporation Ltd stock investments: 1) Short-term Capital Gains (STCG) - If sold within 1 year, gains taxed at 15% plus cess. 2) Long-term Capital Gains (LTCG) - If held over 1 year, gains above ₹1 lakh taxed at 10% without indexation. 3) Dividend Income - Dividends (current yield: 1.13%) are taxable as per your income tax slab. 4) Securities Transaction Tax (STT) - Applicable on both buy and sell transactions. 5) Intraday Trading - Treated as speculative income, taxed as per slab. Tax laws change periodically, so consult a tax advisor for personalized guidance and latest regulations.
Menu